Clinical Trials in Belgium

• A study to determine if ravulizumab can help preserve kidney function in adults with immunoglobulin A nephropathy (IgAN) Ended
  2023-507851-31-00 Phase III Immunoglobulin A Nephropathy (IgAN) Alexion Pharmaceuticals Inc.
• AMG 193 in Combination with Other Therapies in Subjects with Advanced Gastrointestinal, Biliary Tract, or Pancreatic Cancers With Homozygous… Ended
  2024-511195-33-00 Phase I (Other) Gastrointestinal tract, biliary tract, or pancreatic cancers… Amgen Inc.
• Assessing the Safety, Immune Response, and Early Efficacy of a Candida Vaccine in Women with Recurrent Vulvovaginal Candidiasis: A Randomize… Ended
  2023-507527-28-00 Phase I (FiH) Recurrent vulvovaginal candidiasis LimmaTech Biologics AG
• An open-label randomized trial of zanidatamab for advanced HER2positive biliary tract cancer Ended
  2023-508219-21-00 Phase III BTC - Biliary Tract Cancer Jazz Pharmaceuticals Ireland Limited
• HARMONi-3 Ended
  2024-513087-26-00 Phase III Metastatic Non-small Cell Lung Cancer Summit Therapeutics Inc.
• A Phase 2, Multicenter, Randomized, Placebo-Controlled, Double-Blind Induction Study to Evaluate the Efficacy and Safety of Oral TAK-279 in … Ended
  2023-506769-67-00 Phase II Moderate to Severely Active Ulcerative Colitis Takeda Development Center Americas Inc.
• A Study of Subcutaneously Injected Epcoritamab Plus Oral Lenalidomide Capsules Compared to Intravenously (IV) Infused Rituximab Plus IV Infu… Ended
  2024-510965-41-00 Phase III Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (… AbbVie Deutschland GmbH & Co. KG
• Clinical study to check the Efficacy and Safety of Mitapivat in Patients with Sickle Cell Disease Ended
  2024-515202-84-00 Phase II/III Anemia in subjects with sickle cell disease (SCD) Agios Pharmaceuticals Inc.
• A Study Evaluating the Efficacy and Safety of Divarasib Versus Sotorasib or Adagrasib in Patients with previously treated KRAS G12C-positive… Ended
  2024-510908-37-00 Phase III KRAS G12C-Positive Advanced or Metastatic Non-Small Cell Lun… F. Hoffmann-La Roche AG
• Safety and preliminary efficacy of BNT314 in cancer patients with malignant solid tumors Ended
  2023-506053-38-00 Phase I Advanced or metastatic malignant solid tumors BioNTech SE
• A study to investigate long-term follow-up in subjects who received BMN 270 in a prior BioMarin Clinical Trial with hemophilia A Ended
  2023-507749-27-00 Phase IV Hemophilia A Biomarin Pharmaceutical Inc.
• A clinical study of MK-2870 in people with stomach cancer (MK-2870-015) Ended
  2023-505423-31-00 Phase III advanced or metastatic gastric adenocarcinoma, gastroesophag… Merck Sharp & Dohme LLC
• Phase I/II study of ANV600 single agent or in combination with pembrolizumab in participants with advanced solid tumors (EXPAND-1) Ended
  2023-509633-39-00 Phase I (FiH) Advanced solid tumours Anaveon AG
• Phase 3 Study of ALXN1850 versus Placebo in Adolescent and Adult Participants with HPP who have not previously been treated with Asfotase Al… Ended
  2023-505673-32-00 Phase III Hypophosphatasia Alexion Pharmaceuticals Inc.
• An extension and crossover vaccination study on the immune response and safety of a vaccine against respiratory syncytial virus given to adu… Ended
  2023-509762-38-00 Phase III Respiratory Syncytial Virus Infections GlaxoSmithKline Biologicals
• A study to test the effects and safety of riliprubart in people with chronic inflammatory demyelinating polyneuropathy (CIDP) for which the … Ended
  2023-506503-26-00 Phase III Polyneuropathy, Inflammatory Demyelinating, Chronic Sanofi-Aventis Recherche & Developpement
• Selective Treatment of Oral Povorcitinib in Hidradenitis Suppurativa Long-Term Extension Study (STOP-HS LTE) Ended
  2023-507204-31-00 Phase III Hidradenitis Suppurativa Incyte Corp.
• A study to find how well Dazodalibep works and how safe it is in participants with Sjögren’s Syndrome Ended
  2023-503923-24-00 Phase III Sjögren’s Syndrome With Moderate-toSevere Symptom State Horizon Therapeutics Ireland Designated Activity Company
• HOVON 169 CAD: Phase II trial of Zanubrutinib in primary Cold Agglutinin Disease. CaZa study Ended
  2023-505746-25-00 Phase II Cold agglutinin disease Haemato Oncology Foundation For Adults Netherlands
• An Open-label Extension Study Evaluating the Long-term Safety and Efficacy of Seralutinib Orally Inhaled for the Treatment of Pulmonary Arte… Ended
  2023-506334-75-00 Phase III Pulmonary Arterial Hypertension GB002 Inc.
• A study concerning the influence of tubal flushing with oil on pregnancy and live birth in women with fertility problems Ended
  2023-508896-35-00 Phase IV Infertile women with at least one patent tube at Hysterosalp… Antwerp University Hospital
• A Double-blind, Placebo-controlled, Phase IIb, Multi-center, Twelve-week Prospective Study to Evaluate the Efficacy and Safety of Gemlapodec… Ended
  2023-505086-83-00 Phase II Tourette Syndrome Noema Pharma AG
• AN INTERVENTIONAL SAFETY AND EFFICACY PHASE 1B/2, OPEN-LABEL STUDY TO INVESTIGATE TOLERABILITY, PK, AND ANTITUMOR ACTIVITY OF VEPDEGESTRANT … Ended
  2023-508130-33-00 Phase I/II ADVANCED OR METASTATIC BREAST CANCER Pfizer Inc.
• A phase II, randomized, open-label study comparing salvage radiotherapy in combination with 6 months of androgen-deprivation therapy (ADT) w… Ended
  2024-512023-37-00 Phase II Prostate cancer Ziekenhuis Aan De Stroom

Showing 1,177–1,200 of 2,373 trials